| peginterferon alfa-2b |
EU/1/00/ 131/043 |
Pegintron, Powder and solvent for solution for injection, 120, mсg, Pack: 1 |
Merck Sharp & Dohme Ltd., Обединено Кралство |
SP (Brinny) Company, Ireland |
341.92 |
68.38 |
410.3 |
4% |
10 |
351.92 |
70.38 |
422.3 |
16% |
25 |
376.92 |
75.38 |
452.3 |
|
КЦРР-2283/20.02.2013 |
18.03.2013 |
Неактивен |
3694 |
| peginterferon alfa-2b |
EU/1/00/131/047 |
Pegintron, Powder and solvent for solution for injection, 150, mсg, Pack: 1 |
Merck Sharp & Dohme Ltd., Обединено Кралство |
SP Labo N.V. Belgium |
422.34 |
84.47 |
506.81 |
4% |
10 |
432.34 |
86.47 |
518.81 |
16% |
25 |
457.34 |
91.47 |
548.81 |
|
КЦРР-2419/22.02.2013 |
18.03.2013 |
Неактивен |
3366 |
| peginterferon alfa-2b |
EU/1/00/131/035 |
Pegintron, Powder and solvent for solution for injection, 80, mсg, Pack: 1 |
Merck Sharp & Dohme Ltd., Обединено Кралство |
SP (Brinny) Company, Ireland |
237.89 |
47.58 |
285.47 |
4% |
9.52 |
247.41 |
49.48 |
296.89 |
16% |
25 |
272.41 |
54.48 |
326.89 |
КЦPP-1149/02.08.2012 за промяна на обстоятелства |
КЦ-331/28.11.2008 |
25.12.2008 |
Неактивен |
3695 |
| peginterferon alfa-2b |
EU/1/00/131/039 |
Pegintron, Powder and solvent for solution for injection, 100, mсg, Pack: 1 |
Merck Sharp & Dohme Ltd., Обединено Кралство |
SP (Brinny) Company, Ireland |
298.36 |
59.67 |
358.03 |
4% |
10 |
308.36 |
61.67 |
370.03 |
16% |
25 |
333.36 |
66.67 |
400.03 |
КЦPP-1635/15.11.2012 за промяна на обстоятелства |
КЦ-331/28.11.2008 |
25.12.2008 |
Неактивен |
3140 |
| peginterferon alfa-2b |
EU/1/00/131/043 |
Pegintron, Powder and solvent for solution for injection, 120, mсg, Pack: 1 |
Merck Sharp & Dohme Ltd., Обединено Кралство |
SP (Brinny) Company, Ireland |
357.88 |
71.58 |
429.46 |
4% |
10 |
367.88 |
73.58 |
441.46 |
16% |
25 |
392.88 |
78.58 |
471.46 |
КЦPP-1149/02.08.2012 за промяна на обстоятелства |
КЦ-331/28.11.2008 |
25.12.2008 |
Неактивен |
3694 |
| peginterferon alfa-2b |
EU/1/00/131/043 |
PegIntron, Powder and solvent for solution for injection, 120 mcg/0,5 ml, -, Pack: 1 pen (pre-filled pen (cartridge, glass) + 1 injection needle + 2 cleansing swabs |
Merck Sharp & Dohme Ltd., Обединено Кралство |
SP (Brinny) Company, Ireland |
323.12 |
64.62 |
387.74 |
4% |
10 |
333.12 |
66.62 |
399.74 |
16% |
25 |
358.12 |
71.62 |
429.74 |
|
; НСР-9397/01.06.2016 |
02.07.2016 |
Активен |
3694 |
| peginterferon alfa-2b |
EU/1/00/131/043 |
PegIntron, Powder and solvent for solution for injection, 120 mcg/0,5 ml, -, Pack: 1 pen (pre-filled pen (cartridge, glass) + 1 injection needle + 2 cleansing swabs |
Merck Sharp & Dohme Ltd., Обединено Кралство |
SP (Brinny) Company, Ireland |
324.92 |
64.98 |
389.9 |
4% |
10 |
334.92 |
66.98 |
401.9 |
16% |
25 |
359.92 |
71.98 |
431.9 |
|
НСР-5830/19.03.2015 |
02.04.2015 |
Неактивен |
3694 |
| peginterferon alfa-2b |
EU/1/00/ 131/035 |
PegIntron, Powder and solvent for solution for injection, 80 mcg/0,5 ml, -, Pack: 1 pen (pre-filled pen (cartridge, glass) + 1 injection needle + 2 cleansing swabs |
Merck Sharp & Dohme Ltd., Обединено Кралство |
SP (Brinny) Company, Ireland |
216.84 |
43.37 |
260.21 |
4% |
8.67 |
225.51 |
45.1 |
270.61 |
16% |
25 |
250.51 |
50.1 |
300.61 |
|
; НСР-9398/01.06.2016 |
02.07.2016 |
Активен |
3695 |
| peginterferon alfa-2b |
EU/1/00/ 131/035 |
PegIntron, Powder and solvent for solution for injection, 80 mcg/0,5 ml, -, Pack: 1 pen (pre-filled pen (cartridge, glass) + 1 injection needle + 2 cleansing swabs |
Merck Sharp & Dohme Ltd., Обединено Кралство |
SP (Brinny) Company, Ireland |
218.6 |
43.72 |
262.32 |
4% |
8.74 |
227.34 |
45.47 |
272.81 |
16% |
25 |
252.34 |
50.47 |
302.81 |
|
НСР-5829/19.03.2015 |
02.04.2015 |
Неактивен |
3695 |
| peginterferon alfa-2b |
EU/1/00/131/047 |
PegIntron, Powder and solvent for solution for injection, 150 mcg/0,5 ml, -, Pack: 1 pen (pre-filled pen (cartridge, glass) + 1 injection needle + 2 cleansing swabs |
Merck Sharp & Dohme Ltd., Обединено Кралство |
SP Labo N.V., Белгия |
409.28 |
81.86 |
491.14 |
4% |
10 |
419.28 |
83.86 |
503.14 |
16% |
25 |
444.28 |
88.86 |
533.14 |
|
НСР-8251/22.02.2016 |
09.03.2016 |
Активен |
3366 |
| peginterferon alfa-2b |
EU/1/00/ 131/039 |
PegIntron, Powder and solvent for solution for injection, 100 mcg/0,5 ml, -, Pack: 1 pen (pre-filled pen (cartridge, glass) + 1 injection needle + 2 cleansing swabs |
Merck Sharp & Dohme Ltd., Обединено Кралство |
SP (Brinny) Company, Ireland |
264.55 |
52.91 |
317.46 |
4% |
10 |
274.55 |
54.91 |
329.46 |
16% |
25 |
299.55 |
59.91 |
359.46 |
|
НСР-4301/05.08.2014 |
20.08.2014 |
Активен |
3140 |
| Pemetrexed |
20150418 |
Pemetrexed Alvogen, Powder for concentrate for solution for infusion, 500, mg, Pack: 1 |
Alvogen IPCo S.àr.l, Люксембург |
Synthon Hispania SL, Испания; Synthon s.r.o, Чешка Република |
1408.73 |
281.75 |
1690.48 |
4% |
10 |
1418.73 |
283.75 |
1702.48 |
16% |
25 |
1443.73 |
288.75 |
1732.48 |
|
НСР-7945/28.01.2016 (допуска предварително изпълнение) |
28.01.2016 |
Активен |
4171 |
| Pemetrexed |
EU/1/15/1037/002 |
Pemetrexed Sandoz, Powder for concentrate for solution for infusion, 500, mg, Pack: 1 |
Sandoz GmbH, Австрия |
Ebewe Pharma GmbH Nfg. KG, Австрия; Lek Pharmaceuticals d.d., Словения |
1409.72 |
281.94 |
1691.66 |
4% |
10 |
1419.72 |
283.94 |
1703.66 |
16% |
25 |
1444.72 |
288.94 |
1733.66 |
|
НСР-7702/11.12.2015. |
11.12.2015 |
Активен |
4138 |
| Finasteride |
№ 6571/ 16.01.2010 |
PENESTER, Film‐coated tablet, 5, mg, Pack: 30 |
Zentiva k.s., Чешка република |
Zentiva k.s.Чехия |
9.17 |
1.83 |
11 |
7% |
0.64 |
9.81 |
1.96 |
11.77 |
20% |
1.83 |
11.64 |
2.33 |
13.97 |
|
НСР-6600/01.08.2015 |
17.07.2015 |
Активен |
1224 |
| Finasteride |
№ 6571/16.01.2010 |
PENESTER, Film‐coated tablet, 5, mg, Pack: 30 |
Zentiva k.s., Чешка република |
Zentiva k.s.Чехия |
18.58 |
3.72 |
22.3 |
8% |
1.49 |
20.07 |
4.01 |
24.08 |
20% |
3.72 |
23.79 |
4.76 |
28.55 |
издадена корекционна КЦ-2068/17.03.2011 |
КЦ-1951/25.01.2011 |
10.02.2011 |
Неактивен |
1224 |
| Finasteride |
№ 6571/ 16.01.2010 |
PENESTER, Film‐coated tablet, 5, mg, Pack: 30 |
Zentiva k.s., Чешка република |
Zentiva k.s.Чехия |
14.86 |
2.97 |
17.83 |
6% |
0.89 |
15.75 |
3.15 |
18.9 |
18% |
2.67 |
18.42 |
3.68 |
22.1 |
|
КЦРР-492/19.04.2012 |
06.05.2012 |
Неактивен |
1224 |
| diphtheria-pertussis-poliomyelitis-tetanus |
II-9935/15.06.2010 |
Pentaxim, Powder and solvent for suspension for injection, , -, Pack: 1 vial powder, 1 pre-filled syringe 0.5ml for susp., 2 needles |
Sanofi Pasteur S.A., Франция |
Sanofi Pasteur S.A., France / Sanofi Aventis Zrt - 1225 Budapest-Campona u. 1. (Harbor Park) - Унгария |
38.47 |
7.69 |
46.16 |
4% |
1.54 |
40.01 |
8 |
48.01 |
16% |
6.16 |
46.17 |
9.23 |
55.4 |
промяна на обстоятелства НСР-5018/17.11.2014; корекц.HCP-5274/10.12.2014 |
КЦРР-997/23.07.2012 г |
23.01.2013 |
Активен |
1542 |
| diphtheria-pertussis-poliomyelitis-tetanus |
II-9935/15.06.2010 |
Pentaxim, Powder and solvent for suspension for injection, , -, Pack: 1 vial powder, 1 pre-filled syringe 0.5ml for susp. |
Sanofi Pasteur S.A., Франция |
Sanofi Pasteur S.A., France / Sanofi Aventis Zrt - 1225 Budapest-Campona u. 1. (Harbor Park) - Унгария |
38.47 |
7.69 |
46.16 |
4% |
1.54 |
40.01 |
8 |
48.01 |
16% |
6.16 |
46.17 |
9.23 |
55.4 |
промяна на обстоятелства НСР-5019/17.11.2014; корекц.HCP-5273/10.12.2014 |
КЦРР-997/23.07.2012 г |
23.01.2013 |
Активен |
1541 |
| diphtheria-pertussis-poliomyelitis-tetanus |
II-11426/25.08.2005 |
Pentaxim, Powder and solvent for suspension for injection, , -, Pack: 1 |
Sanofi Pasteur S.A., Франция |
Sanofi Pasteur S.A., France |
41.07 |
8.21 |
49.28 |
4% |
1.64 |
42.71 |
8.54 |
51.25 |
16% |
6.57 |
49.28 |
9.86 |
59.14 |
|
КЦ-723/16.03.2009 |
03.04.2009 |
Неактивен |
1542 |
| diphtheria-pertussis-poliomyelitis-tetanus |
13729/24.07.2006 г. |
Pentaxim, Powder and suspension for suspension for injection, , -, Pack: 1 |
Sanofi Pasteur S.A., Франция |
Sanofi Pasteur S.A., France |
41.07 |
8.21 |
49.28 |
4% |
1.64 |
42.71 |
8.54 |
51.25 |
16% |
6.57 |
49.28 |
9.86 |
59.14 |
|
КЦ-723/16.03.2009 |
03.04.2009 |
Неактивен |
1541 |
| Pentoxifylline |
II-14597/23.10.2006 |
PENTILIN, Solution for injection/infusion, 20 mg/ml - 5 ml, mg, Pack: 5 |
KRKA, d.d., Словения |
KRKA, d.d. Novo Mesto, Slovenia |
2.76 |
0.55 |
3.31 |
7% |
0.19 |
2.95 |
0.59 |
3.54 |
20% |
0.55 |
3.5 |
0.7 |
4.2 |
|
КЦ-326/28.11.2008 |
30.12.2008 |
Активен |
299 |
| Pentoxifylline |
II-14598/23.10.2006 |
PENTILIN, Prolonged‐release tablet, 400, mg, Pack: 20 |
KRKA, d.d., Словения |
KRKA, d.d. Novo Mesto, Slovenia |
3.13 |
0.63 |
3.76 |
7% |
0.22 |
3.35 |
0.67 |
4.02 |
20% |
0.63 |
3.98 |
0.8 |
4.78 |
Цената е вписана в регистъра на пределните цени с решение НСР-2689/03.02.2014 |
КЦ-326/28.11.2008 |
30.12.2008 |
Заличен |
289 |
| Pentoxifylline |
II-16386/12.04.2007 г. |
PENTOFYLLIN, Solution for injection, 20 mg/ ml - 5ml, mg, Pack: 10 |
Софарма АД, България |
Софарма АД, ул."Илиенско шосе"16, 1220 София, България |
7.5 |
1.5 |
9 |
7% |
0.53 |
8.03 |
1.61 |
9.64 |
20% |
1.5 |
9.53 |
1.91 |
11.44 |
|
КЦ-275/14.11.2008 |
06.12.2008 |
Активен |
144 |
| Pentoxifylline |
ІІ-14627/23.10.2006 г. |
PentoHEXAL600, Prolonged‐release tablet, 600, mg, Pack: 30 |
Hexal AG, Германия |
Salutas Pharma GmbH, Germany; Lek S.A., Poland |
7.33 |
1.47 |
8.8 |
7% |
0.51 |
7.84 |
1.57 |
9.41 |
20% |
1.47 |
9.31 |
1.86 |
11.17 |
|
КЦ-527/13.02.2009 |
02.03.2009 |
Активен |
517 |
| Pentoxifylline |
20040111 |
PENTOXIFYLLIN-TCHAIKAPHARMA, Prolonged‐release tablet, 400, mg, Pack: 20 |
Чайкафарма Висококачествените лекарства АД, България |
Чайкафарма Висококачествените лекарства АД - гр. Варна / Чайкафарма Висококачествените лекарства АД - гр. Пловдив |
3.72 |
0.74 |
4.46 |
7% |
0.26 |
3.98 |
0.8 |
4.78 |
20% |
0.74 |
4.72 |
0.94 |
5.66 |
|
НСР-5068/21.11.2014 |
08.12.2014 |
Активен |
3367 |